6 results match your criteria: "Kabgayi Hospital[Affiliation]"
Two-step transconjunctival approach for suprachoroidal haemorrhage prior to clot liquefaction.
J Fr Ophtalmol
January 2025
St Paul's Eye Unit, Royal Liverpool Hospital, Royal Liverpool and Broadgreen NHS Foundation Trust, Prescot Road, Liverpool, United Kingdom.
Distribution and causes of blindness and severe visual impairment in children at a tertiary referral centre in Rwanda.
Br J Ophthalmol
January 2024
Pediatric Ophthalmology, The Fondation Adolphe de Rothschild Hospital, Paris, France.
Article Synopsis
- - The study aimed to find out how common severe visual impairment and blindness (SVI/BL) are in children at a medical center in Rwanda and identify the main causes.
- - Among the 3,939 children examined, 428 had SVI/BL, with 165 having it in both eyes and 263 in just one eye, and a significant number of cases were preventable.
- - The leading causes of bilateral conditions were cataract and refractive errors, while trauma was the primary cause of unilateral cases, suggesting that many SVI/BL instances could be avoided with effective interventions.
Glaucoma Surgery Outcome in Rwanda.
J Glaucoma
August 2016
*Department of Ophthalmology, Kabgayi Hospital, Kabgayi, Gitarama, Rwanda †London School of Hygiene and Tropical Medicine §Institute of Ophthalmology, University College London ∥Glaucoma Department, Moorfields Eye Hospital, London, UK ‡Department of Psychology, Stockholm University, Stockholm, Sweden.
Purpose: To assess long-term intraocular pressure (IOP) outcome after adult trabeculectomy surgery in Central Africa.
Patients And Methods: All adult glaucoma patients who underwent trabeculectomy surgery in the Kabgayi Eye Unit, Rwanda between August 2003 and March 2008 were invited for a follow-up visit. Surgical and clinical data were collected from medical records.
Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care.
Ophthalmology
September 2012
Ophthalmology Department, Kabgayi Hospital, Muhanga, Rwanda.
Objective: We sought to describe the clinical presentation, effect on visual acuity, impact on school attendance, and access to appropriate eye care in children with vernal keratoconjunctivitis (VKC) in Rwanda (Central Africa).
Design: Case-control study nested within a cross-sectional survey.
Participants: We examined 3041 children; 121 had VKC.
Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
Br J Ophthalmol
March 2012
Department of Ophthalmology, Kabgayi Hospital, Muhanga, Rwanda.
Aim: To compare the short-term efficiency and safety of topical ciclosporin A (CsA) 2% with dexamethasone 0.1% in the treatment of predominantly limbal vernal keratoconjunctivitis (VKC) in Rwanda, Central Africa.
Methods: Consecutive patients with VKC were randomised in a prospective, double-masked, clinical trial to receive either topical CsA 2% dissolved in olive oil vehicle or dexamethasone 0.
Vernal keratoconjunctivitis in school children in Rwanda and its association with socio-economic status: a population-based survey.
Am J Trop Med Hyg
October 2011
Ophthalmology Department, Kabgayi Hospital, Muhanga, Rwanda.
Vernal keratoconjunctivitis (VKC) is an allergic eye disease and an important cause of hospital referral among children in Africa and Asia. Hospital-based studies have suggested a role for parasites in its pathogenesis. To determine the prevalence and risk factors for VKC in Central Africa, we conducted a nested population-based case control study in Rwanda, involving randomly selected primary schools from different environments (rural/urban) and climate.
View Article and Find Full Text PDF